Tim Somervaille Cancer Research UK (United Kingdom)

SomervailleTim

Wednesday, 18 June 2025

Time Session
09:20
10:55
Symposium: New Drugs on the Horizon
Co-Chair: Jukka Westermarck  (Finland)
Co-Chair: Maria M. Caffarel  (Spain)
  • Drugging transcription factors: HSF1 and Brachyury
    Speaker: Paul Workman  (United Kingdom)
  • Proffered Paper: Selected from Abstracts - to be announced in 2025
  • Targeting chromatin proteins for therapeutic benefit in haematological malignancy
    Speaker: Tim Somervaille  (United Kingdom)
  • Proffered Paper: Selected from Abstracts - to be announced in 2025
  • PP2A inhibitor protein CIP2A is a prime target for TNBC therapy
    Speaker: Jukka Westermarck  (Finland)
Auditorium 1